Bloom K.

Publications

34

Citations

923

h-index

14

Publishing journals

22

Years of publications

17

Active since

2009

References

2.5K

Institutions

3

1. Lipid Nanoparticle-Encapsulated TALEN-Encoding mRNA Inactivates Hepatitis B Virus Replication in Cultured Cells and Transgenic Mice.
   Viruses, Volume 17, Issue 8, Page 1090, Year 2025
2. Bridging gene therapy and next-generation vaccine technologies
   Gene Therapy, Volume 32, Issue 1, No. eabl9900, Pages 4-7, Year 2025
3. The disparate burden of infectious diseases
   Gene Therapy, Volume 32, Issue 1, Pages 1-3, Year 2025
4. Correction to: The disparate burden of infectious diseases (Gene Therapy, (2025), 32, 1, (1-3), 10.1038/s41434-024-00501-w)
   Gene Therapy, Volume 32, Issue 1, Pages 74-74, Year 2025
5. Production, Characterization, and Assessment of Permanently Cationic and Ionizable Lipid Nanoparticles for Use in the Delivery of Self-Amplifying RNA Vaccines
   Pharmaceutics, Volume 15, Issue 4, No. 1173, Page 1173, Year 2023
6. Recent Advances Using Genetic Therapies Against Infectious Diseases and for Vaccination
   Human Gene Therapy, Volume 34, Issue 17-18, Pages 896-904, Year 2023
7. Hepatitis B Virus Research in South Africa
   Viruses, Volume 14, Issue 9, No. 1939, Pages 1939-1939, Year 2022
8. Advancing mRNA technologies for therapies and vaccines: An African context
   Frontiers in Immunology, Volume 13, No. 1018961, Year 2022
9. Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma
   Frontiers in Immunology, Volume 13, No. 834650, Year 2022
10. Synthetic mRNA Gene Therapies and Hepatotropic Non-viral Vectors for the Treatment of Chronic HBV Infections
    RNA Technologies, Volume 13, Pages 157-179, Year 2022
11. Self-amplifying RNA vaccines for infectious diseases
    Gene Therapy, Volume 28, Issue 3-4, Pages 117-129, Year 2021
12. Improved specificity and safety of anti-hepatitis b virus talens using obligate heterodimeric foki nuclease domains
    Viruses, Volume 13, Issue 7, No. 1344, Pages 1344-1344, Year 2021
13. Silencing hepatitis B virus covalently closed circular DNA: The potential of an epigenetic therapy approach
    World Journal of Gastroenterology, Volume 27, Issue 23, Pages 3182-3207, Year 2021
14. Hepatitis B virus: promising drug targets and therapeutic implications
    Expert Opinion on Therapeutic Targets, Volume 25, Issue 6, Pages 451-466, Year 2021
15. Recent Update on the Role of Circular RNAs in Hepatocellular Carcinoma
    Journal of Hepatocellular Carcinoma, Volume Volume 8, Pages 1-17, Year 2021
16. Retroviral UNC13D Gene Transfer Restores Cytotoxic Activity of T Cells Derived from Familial Hemophagocytic Lymphohistiocytosis Type 3 Patients In Vitro
    Human gene therapy, Volume 30, Issue 8, Pages 975-984, Year 2019
17. Inhibition of replication of hepatitis B virus using transcriptional repressors that target the viral DNA
    BMC Infectious Diseases, Volume 19, Issue 1, No. 802, Pages 802-802, Year 2019
18. A Convenient Method to Generate and Maintain Poly(A)-Encoding DNA Sequences Required for in Vitro Transcription of mRNA
    BioTechniques, Volume 66, Issue 1, Pages 37-38, Year 2019
19. Gene and cell therapy in South Africa: Current status and future prospects
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, Volume 109, Issue 8b, Pages 12-16, Year 2019
20. Gene therapy for chronic HBV—Can we eliminate cccDNA?
    Genes, Volume 9, Issue 4, No. 207, Pages 207-207, Year 2018

No publications in the index yet.